Schlafens: Emerging Therapeutic Targets
Article in Cancers (May 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance
Article in Molecular Cancer (April 2024)
The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence
Article in PLOS ONE (April 2024)